There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tempest Therapeutics (TPST – Research Report), Icecure Medical (ICCM – Research Report) and Praxis Precision Medicines (PRAX – Research Report) with bullish sentiments.
Tempest Therapeutics (TPST)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Tempest Therapeutics, with a price target of $35.00. The company’s shares closed last Monday at $0.31, close to its 52-week low of $0.29.
According to TipRanks.com, Pantginis is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Tempest Therapeutics is a Moderate Buy with an average price target of $35.00.
See Insiders’ Hot Stocks on TipRanks >>
Icecure Medical (ICCM)
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Icecure Medical, with a price target of $3.00. The company’s shares closed last Monday at $0.86, close to its 52-week low of $0.52.
According to TipRanks.com, Chen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Icecure Medical with a $2.30 average price target, implying a 155.6% upside from current levels. In a report issued on September 20, Alliance Global Partners also maintained a Buy rating on the stock with a $1.90 price target.
Praxis Precision Medicines (PRAX)
In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Praxis Precision Medicines, with a price target of $7.00. The company’s shares closed last Monday at $1.67.
According to TipRanks.com, Tsao is a 4-star analyst with an average return of
Praxis Precision Medicines has an analyst consensus of Strong Buy, with a price target consensus of $11.67, representing a 555.6% upside. In a report released yesterday, Truist Financial also maintained a Buy rating on the stock with a $10.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TPST:
